1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Deregulating the Finnish OTC-drug market- a cost-benefit analysis
(
- Master (Two yrs)
- 2010
-
Mark
Survival on the Reregulated Swedish Pharmacy Market - The former monopoly Apoteket AB responds to competition
(
- Master (One yr)